Teligene

Company Deals

Suzhou Teligene Ltd Plans IPO on Shanghai STAR Market for Cancer Drug Development

Fineline Cube Jun 23, 2022

China-based Suzhou Teligene Ltd has announced plans for an initial public offering (IPO) of 63.52...

Company Drug

Shionogi Submits Rolling NDA for Ensitrelvir in US for COVID-19 Prophylaxis

Policy / Regulatory

China’s National Health Commission Outlines Key Tasks for Primary Healthcare Reform in 2025

Company Drug

Pfizer Expands Abrysvo RSV Vaccine Indication to Include Ages 18-59 in EU

Company Drug Legal / IP

AccurEdit’s ARTbase-A1 Base Editor Authorized by USPTO